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A template image of dopamine D2 receptor density was derived from 6 PET 
scans in healthy volunteers using the high affinity D2/D3 antagonist ligand 
[18F]-Fallypride. Brain mRNA expression values for DRD2 gene (coding 
for D2R) were extracted from the ABA dataset by using the MENGA tool-
box. CBF contrast images and the [18F]Fallypride BPND template were 
segmented into 83 ROIs by using the Desikan-Killiany Atlas. The regional 
changes in CBF against placebo (∆CBF) were compared with regional 
BPND values and gene expression maps using multivariate correlations.
Results: For all antipsychotics, CBF changes in each ROI were directly pro-
portional to [18F]Fallypride non displaceable binding potential (BPND) 
values (OLA R2= 0.24, HAL R2= 0.61, lowRIS R2= 0.54, highRIS 
R2= 0.52, all p<0.001) and DRD2 mRNA expression levels (OLA R2= 
0.04, HAL R2= 0.15, lowRIS R2= 0.19, highRIS R2= 0.20, all chance like-
lihood <2%).
Discussion: In the present study, we were able to show that the CBF increase 
induced by antipsychotic is directly proportional to D2R concentration in 
the brain, as indexed by PET BPND maps and mRNA expression levels. 
Interestingly, the association strength between ∆CBF and brain receptor 
distribution profiles mirrored differential D2R affinity between the tested 
drugs. Overall, these results indicate that CBF increases after administration 
of a single dose of antipsychotics actually reflect known pharmacodynam-
ics profile of these compounds. In addition, these results further reinforce 
previous evidence suggesting the role of D2R blockade as a mechanism 
behind increased CBF induced by antipsychotics. Finally, CBF is ulti-
mately a functional marker and this work is important in bridging the con-
siderable gap between the pharmacokinetic and pharmacodynamic effects 
of compounds with unclear brain functional effects like antipsychotics.
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Background: Studies using the event sampling method (ESM), a struc-
tured diary technique measuring subjective experiences and emotional 
fluctuations in daily life, have consistently shown that individuals report-
ing psychotic experiences display a heightened emotional reactivity to 
minor stressors—a neuropsychological mechanism that likely contributes 
to the development and perpetuation of psychotic experiences. Except a 
few undersized non-replicated candidate-gene studies showing an associ-
ation between genetic variations and elevated momentary stress reactivity, 
genetic underpinnings of emotion reactivity to momentary stressors have 
not been investigated. Therefore, by leveraging a large general population 
twin dataset of ESM, we aimed to investigate—for the first time—whether 
the polygenic risk score (PRS) for schizophrenia moderates stress reactiv-
ity (psychotic experiences (PE) and negative affect (NA) in response to 
momentary stress).
Methods: Data were derived from a general population adolescent and 
young adult twin sample. The total sample included 638 participants 
(Monozygotic  =  202, Dizygotic  =  436). ESM variables were randomly 
measured at 10 times/day over 6 consecutive days. For the main analyses, 
we assessed ESM information on PE (suspiciousness, loss of control, racing 
thoughts, pervasive thoughts, difficulties to express thoughts), NA (feeling 
lonely, anxious, listless, down, guilty), and event-related stress (pleasantness 
of the most important event since last entry); and for additional explora-
tive analyses we assessed social stress (participants were asked with whom 
they are (e.g. nobody or family) and to rate the pleasantness of the social 
situation). PRS were trained on the results from the Psychiatric Genetics 
Consortium-2 SZ. Multilevel regression analyses, taking into account of 
multiple observations nested within twins who were clustered within fam-
ily, were used to analyze the moderating effects of PRS (at p-value < 0.05) 
on the relationship between momentary stress and NA or PE. All analyses 
were adjusted for age, sex and 2 principle components.
Results: There were significant main effects of momentary stress (event 
stress: b = 0.065, p < 0.001, 95% CI = 0.048, 0.082; social stress: b = 0.128; 
p < 0.001; 95% CI = 0.111, 0.145) on PE. However, neither the main effects 
of PRS on PE nor the interaction between PRS and momentary stress 
on PE were significant. The analysis with NA as dependent variable indi-
cated main effects of momentary stress (event stress: b = 0.096; p <0.001; 
95% CI = 0.081, 0.111; social stress: b = 0.180; p < 0.001; 95% CI = 0.164, 
0.197), but no main effect of PRS. There was a significant negative inter-
action between PRS and both event-related stress (b = -0.016; p = 0.024; 
95% CI  =  -0.031, -0.002) and social stress (b  =  -0.017; p  =  0.024; 95% 
CI = -0.031, -0.002) on NA.
Discussion: This is the first study investigating the influence of molecular 
genetic risk for schizophrenia on momentary stress reactivity, measured 
using an ecologically valid diary method. These results suggest that PRS 
for schizophrenia does not have an effect on psychotic stress responses, 
while increased genetic risk for schizophrenia showed a buffering effect on 
the association between momentary stress and NA. It is possible that indi-
viduals with high PRS for schizophrenia might have emotional response 
deficits, a characteristic of the clinical phenotype. Alternatively, these indi-
viduals might have been less accurate in self-evaluating momentary stress, 
attributing high values to stressors that genuinely do not have an impact 
on their emotion regulation. Future studies, investigating both clinical and 
general populations, are required to elucidate the impact of PRS on stress 
reactivity.
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Background: The Clinical Record Interactive Search (CRIS) database pro-
vides anonymised data from the full electronic health records of all patients 
at the South London and Maudsley NHS Foundation Trust, a large pro-
vider of secondary mental health care. We have previously shown how the 
large volumes of available CRIS data pertaining to outcomes can be mined 
and integrated with patient data collected by historical research interview.
The applications of this futuristic translational research model are yet to be 
fully explored. The aim of this study is to determine whether transcriptomic 
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